Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Immunoproteasome deficiency alters microglial cytokine response and improves cognitive deficits in Alzheimer's disease-like APPPS1 mice.

Wagner LK, Gilling KE, Schormann E, Kloetzel PM, Heppner FL, Krüger E, Prokop S.

Acta Neuropathol Commun. 2017 Jun 24;5(1):52. doi: 10.1186/s40478-017-0453-5.

2.

Roles of tau protein in health and disease.

Guo T, Noble W, Hanger DP.

Acta Neuropathol. 2017 May;133(5):665-704. doi: 10.1007/s00401-017-1707-9. Epub 2017 Apr 6. Review.

3.

Neuropathological diagnoses and clinical correlates in older adults in Brazil: A cross-sectional study.

Suemoto CK, Ferretti-Rebustini RE, Rodriguez RD, Leite RE, Soterio L, Brucki SM, Spera RR, Cippiciani TM, Farfel JM, Chiavegatto Filho A, Naslavsky MS, Zatz M, Pasqualucci CA, Jacob-Filho W, Nitrini R, Grinberg LT.

PLoS Med. 2017 Mar 28;14(3):e1002267. doi: 10.1371/journal.pmed.1002267. eCollection 2017 Mar.

4.

Alzheimer's disease neuropathologic change, Lewy body disease, and vascular brain injury in clinic- and community-based samples.

Brenowitz WD, Keene CD, Hawes SE, Hubbard RA, Longstreth WT Jr, Woltjer RL, Crane PK, Larson EB, Kukull WA.

Neurobiol Aging. 2017 May;53:83-92. doi: 10.1016/j.neurobiolaging.2017.01.017. Epub 2017 Jan 30.

PMID:
28236716
5.

α-Synuclein increases β-amyloid secretion by promoting β-/γ-secretase processing of APP.

Roberts HL, Schneider BL, Brown DR.

PLoS One. 2017 Feb 10;12(2):e0171925. doi: 10.1371/journal.pone.0171925. eCollection 2017.

6.

TDP-43 pathology and memory impairment in elders without pathologic diagnoses of AD or FTLD.

Nag S, Yu L, Wilson RS, Chen EY, Bennett DA, Schneider JA.

Neurology. 2017 Feb 14;88(7):653-660. doi: 10.1212/WNL.0000000000003610. Epub 2017 Jan 13.

PMID:
28087828
7.

Imaging markers of cerebrovascular pathologies: Pathophysiology, clinical presentation, and risk factors.

Raman MR, Kantarci K, Murray ME, Jack CR Jr, Vemuri P.

Alzheimers Dement (Amst). 2016 Dec 18;5:5-14. doi: 10.1016/j.dadm.2016.12.006. eCollection 2016. Review.

8.

TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.

James BD, Wilson RS, Boyle PA, Trojanowski JQ, Bennett DA, Schneider JA.

Brain. 2016 Sep 30. pii: aww224. [Epub ahead of print]

PMID:
27694152
9.

Post-mortem assessment in vascular dementia: advances and aspirations.

McAleese KE, Alafuzoff I, Charidimou A, De Reuck J, Grinberg LT, Hainsworth AH, Hortobagyi T, Ince P, Jellinger K, Gao J, Kalaria RN, Kovacs GG, Kövari E, Love S, Popovic M, Skrobot O, Taipa R, Thal DR, Werring D, Wharton SB, Attems J.

BMC Med. 2016 Aug 26;14(1):129. doi: 10.1186/s12916-016-0676-5. Review.

10.

An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease.

Sarro L, Tosakulwong N, Schwarz CG, Graff-Radford J, Przybelski SA, Lesnick TG, Zuk SM, Reid RI, Raman MR, Boeve BF, Ferman TJ, Knopman DS, Comi G, Filippi M, Murray ME, Parisi JE, Dickson DW, Petersen RC, Jack CR Jr, Kantarci K.

Alzheimers Dement. 2017 Mar;13(3):257-266. doi: 10.1016/j.jalz.2016.07.003. Epub 2016 Aug 10.

11.

Les nouveaux critères de la Maladie d'Alzheimer - Perspective gériatrique.

Molin P, Rockwood K.

Can Geriatr J. 2016 Jun 29;19(2):74-82. doi: 10.5770/cgj.19.242. eCollection 2016 Jun. French. No abstract available.

12.

The New Criteria for Alzheimer's Disease - Implications for Geriatricians.

Molin P, Rockwood K.

Can Geriatr J. 2016 Jun 29;19(2):66-73. doi: 10.5770/cgj.19.207. eCollection 2016 Jun.

13.

Cerebrovascular pathology and Alzheimer's disease.

Nelson PT.

Lancet Neurol. 2016 Aug;15(9):895-896. doi: 10.1016/S1474-4422(16)30038-2. Epub 2016 Jun 14. No abstract available.

PMID:
27312739
14.

Elevation of brain glucose and polyol-pathway intermediates with accompanying brain-copper deficiency in patients with Alzheimer's disease: metabolic basis for dementia.

Xu J, Begley P, Church SJ, Patassini S, McHarg S, Kureishy N, Hollywood KA, Waldvogel HJ, Liu H, Zhang S, Lin W, Herholz K, Turner C, Synek BJ, Curtis MA, Rivers-Auty J, Lawrence CB, Kellett KA, Hooper NM, Vardy ER, Wu D, Unwin RD, Faull RL, Dowsey AW, Cooper GJ.

Sci Rep. 2016 Jun 9;6:27524. doi: 10.1038/srep27524.

15.

Braak stage and trajectory of cognitive decline in noncognitively impaired elders.

Mufson EJ, Malek-Ahmadi M, Snyder N, Ausdemore J, Chen K, Perez SE.

Neurobiol Aging. 2016 Jul;43:101-10. doi: 10.1016/j.neurobiolaging.2016.03.003. Epub 2016 Mar 10.

16.

Therapeutically relevant structural and functional mechanisms triggered by physical and cognitive exercise.

Suo C, Singh MF, Gates N, Wen W, Sachdev P, Brodaty H, Saigal N, Wilson GC, Meiklejohn J, Singh N, Baune BT, Baker M, Foroughi N, Wang Y, Mavros Y, Lampit A, Leung I, Valenzuela MJ.

Mol Psychiatry. 2016 Nov;21(11):1633-1642. doi: 10.1038/mp.2016.19. Epub 2016 Mar 22.

17.

Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies.

White LR, Edland SD, Hemmy LS, Montine KS, Zarow C, Sonnen JA, Uyehara-Lock JH, Gelber RP, Ross GW, Petrovitch H, Masaki KH, Lim KO, Launer LJ, Montine TJ.

Neurology. 2016 Mar 15;86(11):1000-8. doi: 10.1212/WNL.0000000000002480. Epub 2016 Feb 17.

18.

Suspected non-Alzheimer disease pathophysiology--concept and controversy.

Jack CR Jr, Knopman DS, Chételat G, Dickson D, Fagan AM, Frisoni GB, Jagust W, Mormino EC, Petersen RC, Sperling RA, van der Flier WM, Villemagne VL, Visser PJ, Vos SJ.

Nat Rev Neurol. 2016 Feb;12(2):117-24. doi: 10.1038/nrneurol.2015.251. Epub 2016 Jan 18. Review.

19.

Braak staging, plaque pathology, and APOE status in elderly persons without cognitive impairment.

Mufson EJ, Malek-Ahmadi M, Perez SE, Chen K.

Neurobiol Aging. 2016 Jan;37:147-53. doi: 10.1016/j.neurobiolaging.2015.10.012. Epub 2015 Oct 20.

20.

Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal cohort study.

Jack CR Jr, Therneau TM, Wiste HJ, Weigand SD, Knopman DS, Lowe VJ, Mielke MM, Vemuri P, Roberts RO, Machulda MM, Senjem ML, Gunter JL, Rocca WA, Petersen RC.

Lancet Neurol. 2016 Jan;15(1):56-64. doi: 10.1016/S1474-4422(15)00323-3. Epub 2015 Nov 18.

Supplemental Content

Support Center